A detailed history of Hazlett, Burt & Watson, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Hazlett, Burt & Watson, Inc. holds 15,479 shares of PFE stock, worth $408,026. This represents 0.21% of its overall portfolio holdings.

Number of Shares
15,479
Previous 16,268 4.85%
Holding current value
$408,026
Previous $456,000 1.1%
% of portfolio
0.21%
Previous 0.23%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$27.7 - $31.39 $21,855 - $24,766
-789 Reduced 4.85%
15,479 $451,000
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $17,732 - $20,779
-702 Reduced 4.14%
16,268 $456,000
Q1 2024

Apr 29, 2024

SELL
$25.89 - $29.73 $52,737 - $60,560
-2,037 Reduced 10.72%
16,970 $471,000
Q4 2023

Jan 25, 2024

SELL
$26.13 - $33.94 $37,313 - $48,466
-1,428 Reduced 6.99%
19,007 $548,000
Q3 2023

Nov 02, 2023

BUY
$32.09 - $37.51 $23,233 - $27,157
724 Added 3.67%
20,435 $679,000
Q2 2023

Aug 01, 2023

SELL
$36.12 - $41.79 $29,076 - $33,640
-805 Reduced 3.92%
19,711 $722,000
Q1 2023

Apr 27, 2023

BUY
$39.39 - $51.28 $11,974 - $15,589
304 Added 1.5%
20,516 $835,000
Q4 2022

Jan 25, 2023

BUY
$41.75 - $54.5 $8,266 - $10,791
198 Added 0.99%
20,212 $1.04 Million
Q3 2022

Oct 20, 2022

BUY
$43.76 - $53.42 $61,657 - $75,268
1,409 Added 7.57%
20,014 $874,000
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $27,266 - $32,329
586 Added 3.25%
18,605 $977,000
Q1 2022

May 05, 2022

BUY
$45.75 - $56.69 $824,369 - $1.02 Million
18,019 New
18,019 $933,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hazlett, Burt & Watson, Inc. Portfolio

Follow Hazlett, Burt & Watson, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hazlett, Burt & Watson, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hazlett, Burt & Watson, Inc. with notifications on news.